within Pharmacolibrary.Drugs.ATC.J;

model J01CA17
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 4.8 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2000 / 1000000,
    adminCount     = 1,
    Vd             = 0.012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Temocillin is a narrow-spectrum, beta-lactamase-resistant penicillin antibiotic. It is primarily used for treating infections caused by Gram-negative bacteria, including Enterobacteriaceae that produce extended-spectrum beta-lactamases (ESBLs). Temocillin is not active against Gram-positive organisms or non-fermenters like Pseudomonas aeruginosa. It is approved in some European countries but is not widely used globally.</p><h4>Pharmacokinetics</h4><p>PK parameters were determined in healthy adult volunteers after a single intravenous bolus administration.</p><h4>References</h4><ol><li><p>Matzneller, P, et al., &amp; Zeitlinger, M (2020). Single-dose pharmacokinetics of temocillin in plasma and soft tissues of healthy volunteers after intravenous and subcutaneous administration: a randomized crossover microdialysis trial. <i>The Journal of antimicrobial chemotherapy</i> 75(9) 2650–2656. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkaa176&quot;>10.1093/jac/dkaa176</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32433753/&quot;>https://pubmed.ncbi.nlm.nih.gov/32433753</a></p></li><li><p>Alexandre, K, &amp; Fantin, B (2018). Pharmacokinetics and Pharmacodynamics of Temocillin. <i>Clinical pharmacokinetics</i> 57(3) 287–296. DOI:<a href=&quot;https://doi.org/10.1007/s40262-017-0584-7&quot;>10.1007/s40262-017-0584-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28849402/&quot;>https://pubmed.ncbi.nlm.nih.gov/28849402</a></p></li><li><p>Modr, Z, et al., &amp; Krebs, V (1986). Pharmacokinetics of temocillin after intravenous and intramuscular administration. <i>Czechoslovak medicine</i> 9(4) 181–186. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3102181/&quot;>https://pubmed.ncbi.nlm.nih.gov/3102181</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01CA17;
